Wang X K, Li H, Guo J H, Zhang R Y, Cui F Y, Dong W L
Chinese Center for Disease Control and Prevention of Chronic Non-communicable Diseases, Beijing 100050, China.
School of Public Health, Shandong University, Jinan 250012, China.
Zhonghua Yu Fang Yi Xue Za Zhi. 2025 Mar 6;59(3):328-335. doi: 10.3760/cma.j.cn112150-20241024-00845.
This study utilized data from the non-communicable diseases (NCDs) Progress Monitor Reports (2015, 2017, 2020, 2022) released by World Health Organization (WHO) to analyze the implementation of NCDs prevention and control policies in China from 2014 to 2021 through descriptive statistical method, aiming to provide evidence for strengthening national NCDs strategies. The analysis focuses on WHO-recommended 'best buys' policies for NCDs prevention and control, covering 10 categories (18 interventions): national NCDs targets, mortality data, risk factor surveys, national integrated NCDs policies/strategies/action plans, tobacco demand-reduction measures, harmful use of alcohol reduction measures, unhealthy diet reduction policies, physical activity campaigns, national clinical guidelines for cancer/CVD/diabetes/CRD management, and drug therapy/counselling for cardiovascular diseases. In accordance with the WHO's NCDs progress monitor scoring methodology, policies are assigned 1.0 point for full implementation, 0.5 points for partial implementation, and 0 points for non-implementation or missing data, with a maximum total score of 18.0 points. The analytical metrics encompass the policy implementation score, implementation rate, and period-on-period implementation growth rate. The results showed that China's total policy implementation scores for NCDs prevention and control in 2014, 2016, 2019, and 2021 were consistently higher than the global average (8.5, 10.5, 9.5, 9.5 6.7, 8.3, 8.6, 8.6). From 2014 to 2021, the total score increased by 1.0 point, and the implementation rate improved by 8.9%. From 2014 to 2016, China's total policy implementation score rose from 8.5 to 10.5, primarily driven by improvements in tobacco tax increases and unhealthy diet reduction measures (salt reduction, restrictions on high-fat foods, and regulation of breast-milk substitute sales). However, this progress was partially offset by a decline in scores for physical activity campaigns. From 2016 to 2019, the total score decreased to 9.5, largely due to lower scores in harmful use of alcohol reduction measures (alcohol taxation and advertising bans). From 2019 to 2021, the total score remained stable, with increases in marketing to children restrictions balanced by declines in scores for drug therapy/counselling for cardiovascular diseases. In 2021, China's total policy implementation score (9.5) exceeded the global average (8.6) but fell below the G20 average (11.2). Significant gaps remained compared to top-performing G20 countries such as Turkey (16.5), particularly in tobacco control and restrictions on harmful alcohol use. In conclusion, from 2014 to 2021, China's total policy implementation score for NCDs prevention and control consistently exceeded the global average, demonstrating an upward trend, and various NCDs prevention and control policies have been continuously improved.
本研究利用世界卫生组织(WHO)发布的非传染性疾病(NCDs)进展监测报告(2015年、2017年、2020年、2022年)中的数据,通过描述性统计方法分析了2014年至2021年中国非传染性疾病防控政策的实施情况,旨在为加强国家非传染性疾病战略提供依据。分析重点关注WHO推荐的非传染性疾病防控“最佳购买”政策,涵盖10个类别(18项干预措施):国家非传染性疾病目标、死亡率数据、风险因素调查、国家非传染性疾病综合政策/战略/行动计划、烟草需求减少措施、有害使用酒精减少措施、不健康饮食减少政策、身体活动运动、癌症/心血管疾病/糖尿病/慢性呼吸道疾病管理的国家临床指南以及心血管疾病的药物治疗/咨询。按照WHO的非传染性疾病进展监测评分方法,政策完全实施得1.0分,部分实施得0.5分,未实施或数据缺失得0分,总分最高为18.0分。分析指标包括政策实施得分、实施率和环比实施增长率。结果显示,中国2014年、2016年、2019年和2021年非传染性疾病防控政策的总实施得分始终高于全球平均水平(8.5、10.5、9.5、9.5对6.7、8.3、8.6、8.6)。2014年至2021年,总分提高了1.0分,实施率提高了8.9%。2014年至2016年,中国政策总实施得分从8.5分提高到10.5分,主要得益于烟草税增加和不健康饮食减少措施(减盐、限制高脂肪食品和规范母乳代用品销售)的改善。然而,这一进展部分被身体活动运动得分的下降所抵消。2016年至2019年,总分降至9.5分,主要是由于有害使用酒精减少措施(酒精征税和广告禁令)得分较低。2019年至2021年,总分保持稳定,针对儿童营销限制得分增加,而心血管疾病药物治疗/咨询得分下降,两者相互抵消。2021年,中国政策总实施得分(9.5分)超过全球平均水平(8.6分),但低于二十国集团(G20)平均水平(11.2分)。与土耳其等表现最佳的G20国家(16.5分)相比,仍存在显著差距,尤其是在烟草控制和有害酒精使用限制方面。总之,2014年至2021年,中国非传染性疾病防控政策总实施得分始终超过全球平均水平,呈上升趋势,各项非传染性疾病防控政策不断完善。